The hyperoxidative status in CMT patients depends on an increase in the glutathione-S-transferases (GSTs), a reduction of the glutathione (GSH) pool leading to enhanced oxidized glutathione (GSSG)/GSH ratio, and mitochondrial dysfunction [13,14]. This evidence concerns the gene HPGDS and Charcot-Marie-Tooth disease.